These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 37247115)
21. Harnessing stemness and PD-L1 expression by AT-rich interaction domain-containing protein 3B in colorectal cancer. Liao TT; Lin CC; Jiang JK; Yang SH; Teng HW; Yang MH Theranostics; 2020; 10(14):6095-6112. PubMed ID: 32483441 [No Abstract] [Full Text] [Related]
22. Regulatory mechanisms of microRNAs in colorectal cancer and colorectal cancer stem cells. Shirmohamadi M; Eghbali E; Najjary S; Mokhtarzadeh A; Kojabad AB; Hajiasgharzadeh K; Lotfinezhad P; Baradaran B J Cell Physiol; 2020 Feb; 235(2):776-789. PubMed ID: 31264216 [TBL] [Abstract][Full Text] [Related]
23. Engaging stemness improves cancer immunotherapy. Dianat-Moghadam H; Sharifi M; Salehi R; Keshavarz M; Shahgolzari M; Amoozgar Z Cancer Lett; 2023 Feb; 554():216007. PubMed ID: 36396102 [TBL] [Abstract][Full Text] [Related]
24. MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? Caruso S; Bazan V; Rolfo C; Insalaco L; Fanale D; Bronte G; Corsini LR; Rizzo S; Cicero G; Russo A Oncogenesis; 2012 Nov; 1(11):e32. PubMed ID: 23552465 [TBL] [Abstract][Full Text] [Related]
25. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma. Xiao W; Gao Z; Duan Y; Yuan W; Ke Y J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221 [TBL] [Abstract][Full Text] [Related]
26. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies. Walcher L; Kistenmacher AK; Suo H; Kitte R; Dluczek S; Strauß A; Blaudszun AR; Yevsa T; Fricke S; Kossatz-Boehlert U Front Immunol; 2020; 11():1280. PubMed ID: 32849491 [TBL] [Abstract][Full Text] [Related]
27. Targeting Cancer Stem Cells as the Key Driver of Carcinogenesis and Therapeutic Resistance. Eid RA; Alaa Edeen M; Shedid EM; Kamal ASS; Warda MM; Mamdouh F; Khedr SA; Soltan MA; Jeon HW; Zaki MSA; Kim B Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675306 [TBL] [Abstract][Full Text] [Related]
28. The Identifications and Clinical Implications of Cancer Stem Cells in Colorectal Cancer. Wahab SMR; Islam F; Gopalan V; Lam AK Clin Colorectal Cancer; 2017 Jun; 16(2):93-102. PubMed ID: 28237538 [TBL] [Abstract][Full Text] [Related]
29. Translational potential of cancer stem cells: A review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment. Islam F; Gopalan V; Smith RA; Lam AK Exp Cell Res; 2015 Jul; 335(1):135-47. PubMed ID: 25967525 [TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNAs: Emerging regulators for chemo/immunotherapy resistance in cancer stem cells. Shen C; Yang C; Xia B; You M Cancer Lett; 2021 Mar; 500():244-252. PubMed ID: 33242560 [TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA MALAT1 mediates stem cell-like properties in human colorectal cancer cells by regulating miR-20b-5p/Oct4 axis. Tang D; Yang Z; Long F; Luo L; Yang B; Zhu R; Sang X; Cao G; Wang K J Cell Physiol; 2019 Nov; 234(11):20816-20828. PubMed ID: 31012108 [TBL] [Abstract][Full Text] [Related]
32. The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma. Das PK; Islam F; Lam AK Cells; 2020 Jun; 9(6):. PubMed ID: 32503256 [TBL] [Abstract][Full Text] [Related]
33. Understanding the molecular mechanisms that regulate pancreatic cancer stem cell formation, stemness and chemoresistance: A brief overview. Nagaraju GP; Farran B; Luong T; El-Rayes BF Semin Cancer Biol; 2023 Jan; 88():67-80. PubMed ID: 36535506 [TBL] [Abstract][Full Text] [Related]
34. Cell Therapy as Target Therapy against Colon Cancer Stem Cells. Garza Treviño EN; Quiroz Reyes AG; Rojas Murillo JA; de la Garza Kalife DA; Delgado Gonzalez P; Islas JF; Estrada Rodriguez AE; Gonzalez Villarreal CA Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175871 [TBL] [Abstract][Full Text] [Related]
35. Cancer cells stemness: A doorstep to targeted therapy. Prasad S; Ramachandran S; Gupta N; Kaushik I; Srivastava SK Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165424. PubMed ID: 30818002 [TBL] [Abstract][Full Text] [Related]
36. Clinical Implications of Colorectal Cancer Stem Cells in the Age of Single-Cell Omics and Targeted Therapies. Frank MH; Wilson BJ; Gold JS; Frank NY Gastroenterology; 2021 May; 160(6):1947-1960. PubMed ID: 33617889 [TBL] [Abstract][Full Text] [Related]
37. Colorectal cancer defeating? Challenge accepted! Di Franco S; Todaro M; Dieli F; Stassi G Mol Aspects Med; 2014 Oct; 39():61-81. PubMed ID: 23927966 [TBL] [Abstract][Full Text] [Related]
38. Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells. Chen W; Zhang L; Liu S; Chen C Cells; 2022 Sep; 11(19):. PubMed ID: 36230903 [TBL] [Abstract][Full Text] [Related]
39. Gastrointestinal cancer stem cells as targets for innovative immunotherapy. Chivu-Economescu M; Necula LG; Matei L; Dragu DL; Neagu AI; Alexiu I; Bleotu C; Diaconu CC World J Gastroenterol; 2020 Apr; 26(14):1580-1593. PubMed ID: 32327907 [TBL] [Abstract][Full Text] [Related]
40. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis. Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]